✦ LIBER ✦

A stochastic economic evaluation of Letrozole versus Tamoxifen as a first-line therapy for postmenopausal women with advanced breast cancer

✍ Scribed by J.D. Karnon; T.E.D. Jones

Book ID: 117658706
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 159 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81345-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of anastrozole versus

Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer

✍ W.Robert Simons; David Jones; Aman Buzdar 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Randomised study of anastrozole versus t

Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women

✍ I. Vergote; J. Bonneterre; B. Thürlimann; J. Robertson; M. Krzakowski; L. Mauria 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Efficacy of tamoxifen following anastroz

Efficacy of tamoxifen following anastrozole (‘Arimidex’) compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women

✍ B. Thürlimann; J.F.R. Robertson; J.M. Nabholtz; A. Buzdar; J. Bonneterre 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 247 KB

Cost-effectiveness of letrozole versus t

Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective

✍ Thomas E. Delea; Khalid El-Ouagari; Jonathan Karnon; Oleg Sofrygin 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 301 KB

Randomized Phase III Placebo-Controlled

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

✍ Wolff, A. C.; Lazar, A. A.; Bondarenko, I.; Garin, A. M.; Brincat, S.; Chow, L.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 194 KB

PCN116 A SURVIVAL BASED COST-EFFECTIVENE

PCN116 A SURVIVAL BASED COST-EFFECTIVENESS ANALYSIS OF 5 YEARS LETROZOLE VERSUS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER: CANADIAN PERSPECTIVE

✍ K El Ouagari; S Kaura; JD Karnon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB